Integra LifeSciences reported its financial results for the second quarter of 2017.
Here are six observations:
1. Revenue increased 13.2 percent in the second quarter of 2017, compared to the same period the year prior, hitting $282.2 million.
2. The company's second quarter GAAP gross margin rose 80 basis points to 64.9 percent compared to the second quarter of 2016.
3. The second quarter GAAP net income fell to $10.8 million, due to acquisition and integration expenses.
4. Integra LifeSciences' operating cash flow was valued at $28.9 million, reflecting a decrease from the same period the year prior.
5. The company updated its 2017 revenue guidance to a range of $1.125 billion to $1.14 billion.
6. Additionally, Integra LifeSciences' is updating its 2017 full-year organic sales growth to between 6 percent and 7 percent.